Arrowhead Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ARWR Nasdaq 2834 http://arrowheadpharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arrowhead Pharmaceuticals Inc

Is Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) CEO Paid Enough Relative To Peers? - Sep 20th, 2019 8:19 am
Arrowhead Pharmaceuticals Presents Initial Top-Line Clinical Data and Preclinical Data on RNAi Candidates ARO-APOC3 and ARO-ANG3 - Sep 16th, 2019 1:00 am
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar? - Sep 9th, 2019 4:51 am
Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August - Sep 8th, 2019 5:28 pm
Arrowhead Pharmaceuticals to Participate in Upcoming September 2019 Conferences - Aug 30th, 2019 2:00 pm
Why This Newly Profitable Biotech Stock Is Flirting With A Breakout - Aug 29th, 2019 2:21 pm
Arrowhead Pharmaceuticals and three other stocks to watch - Aug 29th, 2019 9:02 am
Is Arrowhead Pharmaceuticals Inc (ARWR)’s Recently Published U.S. Patent Application A Blockbuster? - Aug 28th, 2019 1:16 pm
Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection - Aug 28th, 2019 5:30 am
Arrowhead Pharmaceuticals: Buy at the High? - Aug 21st, 2019 10:37 am
Arrowhead Pharma Shares Quietly See Big Buy Demand - Aug 19th, 2019 9:44 am
Could The Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Ownership Structure Tell Us Something Useful? - Aug 15th, 2019 9:59 am
BioBoyScout’s Online Biotech Valuation Calculators Help Small Investors See Value in Arrowhead Pharmaceuticals (ARWR) - Aug 15th, 2019 7:00 am
Edited Transcript of ARWR earnings conference call or presentation 5-Aug-19 8:30pm GMT - Aug 12th, 2019 4:10 am
Arrowhead Pharmaceuticals Doses First Patient in SEQUOIA Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease - Aug 8th, 2019 5:30 am
What You'll Want to Know About Arrowhead Pharmaceuticals' Q3 Update - Aug 6th, 2019 4:00 am
Arrowhead Research Corp (ARWR) Q3 2019 Earnings Call Transcript - Aug 5th, 2019 9:23 pm
How Analysts View Arrowhead Pharmaceuticals - Aug 5th, 2019 6:02 pm
Arrowhead Pharmaceuticals Reports Fiscal 2019 Third Quarter Results - Aug 5th, 2019 2:00 pm